secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aveanna Healthcare Holdings, Inc. (AVAH)
CIK:        0001832332
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0000950170-23-061483
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aveanna Q3 revenue up 7.9% to $478M; net loss $102.4M on $105.1M impairment; raises FY guidance
--------------------------------------------------------------------------------

- Revenue $478.0M (+7.9% YoY); gross margin $147.3M (+9.4%).
- Net loss $102.4M includes $105.1M non-cash goodwill impairment vs net income $24.3M in Q3 2022.
- Adjusted EBITDA $36.2M (+46.2% YoY); adjusted net loss per share $(0.03) unchanged.
- FY 2023 revenue guidance raised to $1.87B-$1.88B; Adj. EBITDA guidance raised to $134M-$137M.
- CEO cites continued momentum and execution on 2023 initiatives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832332/000095017023061483/0000950170-23-061483-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832332/000095017023061483/avah-20231109.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-061483

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer